High expression of AP-4 predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy

Tumor Biology

Volumn 34, Issue 1, 2013, Pages 271-276

  Hu, Ben Shun ^a,c   Zhao, Gang ^b   Yu, Hai Feng ^c   Chen, Ke ^c   Dong, Jia Hong ^a   Tan, Jing Wang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

Author keywords

AP 4; Biomarker; Hepatocellular carcinoma; Immunohistochemical analysis; Prognosis

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN; MESSENGER RNA;

ADULT; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR RECURRENCE; TUMOR VOLUME; WESTERN BLOTTING;

EID: 84872818545     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0547-4     Document Type: Article

References (33)

1. MI Shariff IJ Cox AI Gomaa SA Khan W Gedroyc SD TaylorRobinson 2009 Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics Expert Rev Gastroenterol Hepatol 3 353 357 19673623 10.1586/egh.09.35
2. WY Lau EC Lai 2008 Hepatocellular carcinoma: current management and recent advances Hepatobiliary Pancreat Dis Int 7 237 257 18522878
3. D Koorey 2007 Hepatocellular carcinoma: prevention, detection and treatment in the real world Intern Med J 37 513 515 17640186 10.1111/j.1445-5994.2007.01439.x 1:STN:280:DC%2BD2svit1Kjtw%3D%3D
4. M Pleguezuelo L Marelli M Misseri G Germani V Calvaruso E Xiruochakis, et al. 2008 TACE versus TAE as therapy for hepatocellular carcinoma Expert Rev Anticancer Ther 8 1623 1641 18925854 10.1586/14737140.8.10.1623 1:CAS:528:DC%2BD1cXht1yjtbzI
5. ME Massari C Murre 2000 Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms Mol Cell Biol 20 2 429 440 10611221 10.1128/MCB.20.2.429-440.2000 1:CAS:528:DC%2BD3cXjtVKnsg%3D%3D
6. R Grau C Punzon M Fresno MA Iniguez 2006 Peroxisome-proliferator- activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1 Biochem J 395 1 81 88 16343055 10.1042/BJ20050964 1:CAS:528:DC%2BD28XitlSgu7c%3D
7. WR Atchley WM Fitch 1997 A natural classification of the basic helix-loop-helix class of transcription factors Proc Natl Acad Sci USA 94 10 5172 5176 9144210 10.1073/pnas.94.10.5172 1:CAS:528:DyaK2sXjtlalurk%3D
8. SU Lee HO Song W Lee G Singaravelu JR Yu WY Park 2009 Identification and characterization of a putative basic helix-loop-helix (bHLH) transcription factor interacting with calcineurin in C. elegans Mol Cells. 28 5 455 461 19855932 10.1007/s10059-009-0145-5 1:CAS:528:DC%2BD1MXhsFamsrvF
9. N Mermod TJ Williams R Tjian 1988 Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro Nature 332 6164 557 561 2833704 10.1038/332557a0 1:CAS:528:DyaL1cXitVWms7o%3D
10. YF Hu B Luscher A Admon N Mermod R Tjian 1990 Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity Genes Dev 4 10 1741 1752 2123466 10.1101/gad.4.10.1741 1:CAS:528:DyaK3MXitlOq
11. P Jung A Menssen D Mayr H Hermeking 2008 AP4 encodes a c-MYC-inducible repressor of p21 Proc Natl Acad Sci USA 105 39 15046 15051 18818310 10.1073/pnas.0801773105 1:CAS:528:DC%2BD1cXht1alsL3F
12. P Jung H Hermeking 2009 The c-MYC-AP4-p21 cascade Cell Cycle. 8 7 982 989 19270520 10.4161/cc.8.7.7949 1:CAS:528:DC%2BD1MXlvFamtLo%3D
13. Y Cui CS Narayanan J Zhou A Kumar 1998 Exon-I is involved in positive as well as negative regulation of human angiotensinogen gene expression Gene 224 1-2 97 107 9931457 10.1016/S0378-1119(98)00512-5 1:CAS:528:DyaK1MXivVersg%3D%3D
14. R Wang YW Zhang X Zhang R Liu S Hong K Xia, et al. 2006 Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia FASEB J 20 8 1275 1277 16645044 10.1096/fj.06-5839fje
15. K Tsujimoto T Ono M Sato T Nishida T Oguma T Tadakuma 2005 Regulation of the expression of caspase-9 by the transcription factor activator protein-4 in glucocorticoid-induced apoptosis J Biol Chem 280 30 27638 27644 15944155 10.1074/jbc.M501304200 1:CAS:528:DC%2BD2MXmsVyqt7s%3D
16. MY Kim BC Jeong JH Lee HJ Kee H Kook NS Kim, et al. 2006 A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells Proc Natl Acad Sci USA 103 35 13074 13079 16924111 10.1073/pnas.0601915103 1:CAS:528:DC%2BD28XptlWisrg%3D
17. I Unk E Kiss-Toth I Boros 1994 Transcription factor AP-4 participates in activation of bovine leukemia virus long terminal repeat by p34 tax Nucleic Acids Res 22 23 4872 4875 7800474 10.1093/nar/22.23.4872 1:CAS:528: DyaK2MXisl2nurk%3D
18. JA Glahder CN Hansen J Vinther BS Madsen B Norrild 2003 A promoter within the E6 ORF of human papillomavirus type 16 contributes to the expression of the E7 oncoprotein from a monocistronic mRNA J Gen Virol 84 Pt 12 3429 3441 14645924 10.1099/vir.0.19250-0 1:CAS:528:DC%2BD3sXpvFarurw%3D
19. E Fodor SL Weinrich A Meister N Mermod WJ Rutter 1991 A pancreatic exocrine cell factor and AP4 bind overlapping sites in the amylase 2A enhancer Biochemistry 30 33 8102 8108 1714299 10.1021/bi00247a002 1:CAS:528: DyaK3MXkvVKmtLw%3D
20. J Cao M Tang WL Li J Xie H Du WB Tang, et al. 2009 Upregulation of activator protein-4 in human colorectal cancer with metastasis Int J Surg Pathol 17 1 16 21 18480385 1:CAS:528:DC%2BD1MXisFeqtL0%3D
21. TX Lin J Huang H Huang QQ Cai KW Xu XB Yin, et al. 2005 Identification of response element gene sequence for non-steroid hormone transcription factors for the activation and up-regulation of L-plastin expression in prostate cancer Zhonghua Nan Ke Xue. 11 10 731 734 16281503 1:CAS:528:DC%2BD28XhtVKrt7zI
22. W Fang X Li Q Jiang Z Liu H Yang S Wang S Xie Q Liu T Liu J Huang W Xie Z Li Y Zhao E Wang FM Marincola K Yao 2008 Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China J Transl Med. 6 32 10.1186/1479-5876-6-32 18570662 10.1186/1479-5876-6-32
23. L Tu Z Liu X He Y He H Yang Q Jiang S Xie G Xiao X Li K Yao W Fang 2010 Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma Mol Cancer. 9 78 10.1186/1476-4598-9-78 20398343 10.1186/1476-4598-9-78
24. Z Liu L Li Z Yang W Luo X Li H Yang K Yao B Wu W Fang 2010 Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma BMC Cancer. 10 270 10.1186/1471-2407-10-270 20534121 10.1186/1471-2407-10-270
25. X-D Zhu J-B Zhang P-Y Zhuang H-G Zhu W Zhang Y-Q Xiong L Wei-Zhong Wu Z-YT Wang H-C Sun 2008 High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma J Clin Oncol 26 2707 2716 10.1200/JCO.2007.15.6521 18509183 10.1200/JCO.2007.15.6521
26. Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT, Zender L, Lowe SW, Poon RT, Luk JM. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer. 2009;115(19):4576-85. doi: 10.1002/cncr.24495. PMID: 19551889.
27. K Kelly J Crowley PA Bunn Jr CA Presant PK Grevstad CM Moinpour SD Ramsey AJ Wozniak GR Weiss DF Moore VK Israel RB Livingston DR Gandara 2001 Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a Southwest Oncology Group trial J Clin Oncol 19 3210 3218 11432888 1:CAS:528:DC%2BD3MXltlShtb4%3D
28. BT Hennessy EO Hanrahan PA Daly 2004 Non-Hodgkin lymphoma: an update Lancet Oncol 5 341 353 15172354 10.1016/S1470-2045(04)01490-1
29. SY Peng PL Lai JS Chu PH Lee PT Tsung DS Chen, et al. 1993 Expression and hypomethylation of alpha-fetoprotein gene in unicentric and multicentric human hepatocellular carcinomas Hepatology 17 35 41 7678574 10.1002/hep.1840170108 1:CAS:528:DyaK3sXhs1Khu7g%3D
30. HC Hsu YM Jeng TL Mao JS Chu PL Lai SY Peng 2000 β-Catenin mutations are associated with a subset of low stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis Am J Pathol 157 763 770 10980116 10.1016/S0002-9440(10)64590-7 1:CAS:528:DC%2BD3cXmvFWqt78%3D
31. AB Tuck FP O'Malley H Singhal JF Harris KS Tonkin N Kerkvliet, et al. 1998 Osteopontin expression in a group of lymph node negative breast cancer patients Int J Cancer 79 502 508 9761120 10.1002/(SICI)1097-0215(19981023)79: 5<502::AID-IJC10>3.0.CO;2-3 1:CAS:528:DyaK1cXmsVWju7w%3D
32. T Ue H Yokozaki Y Kitadai S Yamamoto W Yasui T Ishikawa, et al. 1998 Co-expression of osteopontin and CD44v9 in gastric cancer Int J Cancer 79 127 132 9583725 10.1002/(SICI)1097-0215(19980417)79:2<127::AID-IJC5>3.0.CO;2-V 1:CAS:528:DyaK1MXksl2kurw%3D
33. YH Hwang JY Choi S Kim, et al. 2004 Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma Hepatol Res 29 113 121 15163433 10.1016/j.hepres.2004.02.009 1:CAS:528:DC%2BD2cXkt1SrtLg%3D